Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Curi Bio Announces Mantarray™ Platform for Analysis of 3D Engineered Muscle Tissues for Discovery of New Therapeutics

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Aigenpulse launches data analysis suite to automate flow cytometry

Aigenpulse launches data analysis suite to automate flow cytometry

Evonetix partners with Analog Devices to fast track the development of DNA desktop writer

Evonetix partners with Analog Devices to fast track the development of DNA desktop writer

Cell signaling research rings warning bells over an emerging cancer drug target

Cell signaling research rings warning bells over an emerging cancer drug target

CN Bio partners with Imperial College London to uncover therapeutic targets for alcoholic hepatitis

CN Bio partners with Imperial College London to uncover therapeutic targets for alcoholic hepatitis

Optibrium’s peer-reviewed study highlights the value of deep learning to impute drug discovery data

Optibrium’s peer-reviewed study highlights the value of deep learning to impute drug discovery data

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

Novel drug could improve life expectancy and quality for patients with hard-to-treat cancers

Insilico Medicine launches new system for COVID-19 basic and clinical research

Insilico Medicine launches new system for COVID-19 basic and clinical research

Metrion Biosciences strengthens global business development team

Metrion Biosciences strengthens global business development team

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

Study links brain astrocyte dysfunction to Parkinson’s disease pathology

New approach can make immunotherapy effective against cancers

New approach can make immunotherapy effective against cancers

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Existing drug masitinib identified as potential inhibitor of SARS-CoV-2

Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications

Hydrophilic Vyon® plastics demonstrate outstanding performance for drug discovery applications

Manipulating 3D Printed Organoid Microenvironments

Manipulating 3D Printed Organoid Microenvironments

SARS discovery boots search for COVID-19 drugs

SARS discovery boots search for COVID-19 drugs

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Axol Bioscience appoints Liam Taylor as Chief Executive Officer

Dotmatics announces the launch of Bioregister 2020.1

Dotmatics announces the launch of Bioregister 2020.1

New aging biomarkers to be presented at 7th annual ARDD conference

New aging biomarkers to be presented at 7th annual ARDD conference

Highly expressed protein in lung cancer cells drives resistance to targeted therapies

Highly expressed protein in lung cancer cells drives resistance to targeted therapies